Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Shivering After Cesarean Delivery
NCT06711913Phase 2Completed
- Sponsor
- Liaquat National Hospital & Medical College
- Start
- Dec 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of dexmedetomidine, sponsored by Liaquat National Hospital & Medical College. Primary endpoint: Shivering at 3 minutes. Started Dec 2023; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT06711913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06711913.